Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,406 | 88 | 85.9% |
| Education | $229.85 | 3 | 14.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $788.29 | 43 | $0 (2022) |
| PFIZER INC. | $195.94 | 12 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $172.12 | 8 | $0 (2023) |
| GENZYME CORPORATION | $111.04 | 6 | $0 (2018) |
| LEO Pharma Inc. | $92.70 | 7 | $0 (2019) |
| AbbVie, Inc. | $86.66 | 5 | $0 (2019) |
| Valeant Pharmaceuticals North America LLC | $53.88 | 1 | $0 (2017) |
| Lilly USA, LLC | $45.62 | 3 | $0 (2018) |
| Amgen Inc. | $43.92 | 3 | $0 (2018) |
| Actelion Pharmaceuticals US, Inc. | $15.69 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $16.81 | 1 | Novartis Pharmaceuticals Corporation ($16.81) |
| 2022 | $23.21 | 1 | Janssen Biotech, Inc. ($23.21) |
| 2021 | $91.09 | 2 | Janssen Biotech, Inc. ($91.09) |
| 2020 | $80.51 | 4 | Novartis Pharmaceuticals Corporation ($40.89) |
| 2019 | $289.41 | 16 | Janssen Biotech, Inc. ($166.91) |
| 2018 | $507.21 | 34 | Janssen Biotech, Inc. ($190.89) |
| 2017 | $627.40 | 33 | Janssen Biotech, Inc. ($294.61) |
All Payment Transactions
91 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/28/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: Dermatology | ||||||
| 03/02/2022 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.21 | General |
| Category: Immunology | ||||||
| 11/18/2021 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: Immunology | ||||||
| 06/28/2021 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $69.95 | General |
| Category: Immunology | ||||||
| 03/05/2020 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: Immunology | ||||||
| 02/14/2020 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: IMMUNOLOGY | ||||||
| 02/12/2020 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: DERMATOLOGY | ||||||
| 01/07/2020 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: IMMUNOLOGY | ||||||
| 12/19/2019 | LEO Pharma Inc. | ENSTILAR (Drug) | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: DERMATOLOGY | ||||||
| 12/12/2019 | Janssen Biotech, Inc. | Tremfya (Drug) | Food and Beverage | In-kind items and services | $10.13 | General |
| Category: Immunology | ||||||
| 11/21/2019 | LEO Pharma Inc. | ENSTILAR (Drug) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: DERMATOLOGY | ||||||
| 11/12/2019 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: DERMATOLOGY | ||||||
| 09/26/2019 | Janssen Biotech, Inc. | Tremfya (Drug) | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: Immunology | ||||||
| 08/23/2019 | Janssen Biotech, Inc. | Tremfya (Drug) | Food and Beverage | In-kind items and services | $12.67 | General |
| Category: Immunology | ||||||
| 08/13/2019 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: DERMATOLOGY | ||||||
| 08/02/2019 | LEO Pharma Inc. | ENSTILAR (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: DERMATOLOGY | ||||||
| 07/17/2019 | Janssen Biotech, Inc. | Tremfya (Drug) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: Immunology | ||||||
| 06/25/2019 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $11.12 | General |
| Category: DERMATOLOGY | ||||||
| 06/18/2019 | AbbVie, Inc. | Skyrizi (Biological) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: Immunology | ||||||
| 06/14/2019 | Janssen Biotech, Inc. | Tremfya (Drug) | Food and Beverage | In-kind items and services | $10.60 | General |
| Category: Immunology | ||||||
| 05/14/2019 | Janssen Biotech, Inc. | Tremfya (Drug) | Education | In-kind items and services | $69.95 | General |
| Category: Immunology | ||||||
| 04/23/2019 | Janssen Biotech, Inc. | Tremfya (Drug) | Food and Beverage | In-kind items and services | $10.62 | General |
| Category: Immunology | ||||||
| 03/26/2019 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: DERMATOLOGY | ||||||
| 03/08/2019 | Janssen Biotech, Inc. | Tremfya (Drug) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: Immunology | ||||||
| 12/04/2018 | GENZYME CORPORATION | DUPIXENT (Drug) | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 4,236 | 6,198 | $1.8M | $392,108 |
| 2022 | 23 | 4,221 | 6,427 | $1.8M | $409,596 |
| 2021 | 24 | 3,862 | 6,114 | $1.7M | $393,407 |
| 2020 | 25 | 3,745 | 8,824 | $1.5M | $342,648 |
All Medicare Procedures & Services
96 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 2,135 | 3,301 | $990,300 | $178,466 | 18.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 722 | 868 | $186,620 | $53,282 | 28.6% |
| 96910 | Therapy procedure using ultraviolet radiation with tar or petroleum jelly application | Office | 2023 | 52 | 427 | $130,235 | $41,765 | 32.1% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 104 | 108 | $119,880 | $26,043 | 21.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 195 | 225 | $59,618 | $16,780 | 28.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 122 | 139 | $49,345 | $11,477 | 23.3% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 30 | 36 | $14,580 | $10,739 | 73.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 168 | 188 | $38,540 | $7,867 | 20.4% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 54 | 66 | $47,190 | $6,611 | 14.0% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2023 | 58 | 66 | $17,980 | $5,927 | 33.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 118 | 132 | $17,820 | $5,316 | 29.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 44 | 51 | $15,300 | $4,915 | 32.1% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 26 | 31 | $15,669 | $4,207 | 26.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 47 | 47 | $12,455 | $3,376 | 27.1% |
| 96567 | Application of light to destroy precancer skin growth | Office | 2023 | 30 | 34 | $11,980 | $3,302 | 27.6% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Office | 2023 | 79 | 84 | $13,860 | $2,680 | 19.3% |
| 11402 | Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 34 | 34 | $16,464 | $2,354 | 14.3% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 30 | 42 | $5,920 | $1,731 | 29.2% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Office | 2023 | 32 | 66 | $6,320 | $1,381 | 21.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 86 | 182 | $5,460 | $934.84 | 17.1% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2023 | 35 | 35 | $4,480 | $921.33 | 20.6% |
| 11422 | Removal of noncancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 11 | 12 | $6,144 | $892.68 | 14.5% |
| 69100 | Biopsy of ear | Office | 2023 | 12 | 12 | $3,499 | $667.83 | 19.1% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 12 | 12 | $2,160 | $473.04 | 21.9% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 2,229 | 3,469 | $1.0M | $186,652 | 17.9% |
About David Wartman
David Wartman is a Dermatology healthcare provider based in Springfield, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/16/2007. The National Provider Identifier (NPI) number assigned to this provider is 1578788659.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, David Wartman has received a total of $1,636 in payments from pharmaceutical and medical device companies, with $16.81 received in 2023. These payments were reported across 91 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,406).
As a Medicare-enrolled provider, Wartman has provided services to 16,064 Medicare beneficiaries, totaling 27,563 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 96 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Other Specialties Dermatology
- Location Springfield, MA
- Active Since 04/16/2007
- Last Updated 11/18/2010
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1578788659
Products in Payments
- Tremfya (Drug) $433.38
- EUCRISA (Drug) $195.94
- STELARA (Biological) $172.58
- COSENTYX (Biological) $155.31
- TREMFYA (Drug) $135.88
- DUPIXENT (Drug) $111.04
- ENSTILAR (Drug) $92.70
- Humira (Biological) $69.96
- SILIQ (Drug) $53.88
- REMICADE (Biological) $46.45
- TALTZ (Drug) $45.62
- Enbrel (Biological) $43.92
- COSENTYX (Drug) $16.81
- Skyrizi (Biological) $16.70
- VALCHLOR MECHLORETHAMINE (Drug) $15.69
- DUPIXENT DUPILUMAB INJECTION (Biological) $15.21
- Otezla (Drug) $14.57
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Springfield
Dr. Shannon Trotter, D.o, D.O
Dermatology — Payments: $261,835
Dr. Peter Demos, M.d, M.D
Dermatology — Payments: $19,423
Dr. Joshua Dimmick, Md, MD
Dermatology — Payments: $14,304
Dr. Vivianne Beyer, M.d, M.D
Dermatology — Payments: $13,294
Dr. Jenifer Insley, Md, MD
Dermatology — Payments: $7,868
Catherine Laughlin, Md, MD
Dermatology — Payments: $6,097